ARCHIVES

Memphis CCOP Withdrawn, Says Lack Of Patient Benefits, Excess Tests Discouraged Local Physicians

This article is from The Cancer Letter archive.

Vol. 10 No. 44 | November 16, 1984

Download PDF Visit The Full Archive

Related Articles

Gleevec Approval Sets Record For FDA Review: 73 Days

May 25, 2001

In Brief: King Faisal Prize Next Year Will Be Awarded For Leukemia Research; Yarbro Wins Fulbirght

March 20, 1987

Anti-Nausea Drug Successful In Phase III Trial in Highly Emetogenic Chemotherapy

May 30, 2014

New NIH Program To Develop Therapies For Rare, Neglected Diseases

June 19, 2009

NCAB Approved NTP Transfer To NIEHS But Without Much Enthusiasm

May 30, 1980

NCI Moves Ahead With Trials Database, Reporting Studies In Progress At Cancer Centers

July 15, 2011